You are here

Targeted Prodrug Therapy of Liver Cancers

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43CA105617-01
Agency Tracking Number: CA105617
Amount: $100,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Timeline
Solicitation Year: 2004
Award Year: 2004
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
ACCLAIM BIOTECHNOLOGY 3520 PLUMB ST
HOUSTON, TX 77005
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 JOHN Chan
 (713) 792-3214
 CHANYHJOHN@HOTMAIL.COM
Business Contact
Phone: (713) 792-3256
Research Institution
N/A
Abstract

DESCRIPTION (provided by applicant): Hepatocellular carcinoma (HCC) and colorectal cancer (CRC) are among the most common and deadly malignancy worldwide. CRC is the second leading cause of cancer-related death in the USA, mostly due to metastases to the

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government